Research & Development
Browse our research documents and publications, view our product pipeline and learn more about our research partners.
Reports, publications, and papers
Browse relevant documents to see the insights and thought leadership that we’ve spear headed over the years.
Exploring Psychosocial Quality of Life Endpoints in Real-World Data in Chronic Inflammatory Diseases
An emerging shift in healthcare real world evidence research is focusing on understanding how psychosocial factors impact patients treatment and disease...
Why Flare Prediction for Inflammatory Bowel Disease Holds Crucial Potential
At Ampersand Health, we are conducting research to improve flare prediction in IBD by utilising machine learning algorithms to analyse patient data, including...
The Cycle of Flare and Remission in Inflammatory Conditions: The Role of Patient-Initiated Follow-up on Quality of Life
This article aims to emphasise the importance of patient-initiated follow-up in managing chronic conditions.
How Digital Health Tools Create a Better Patient Experience
This article will introduce the subject of isolation in chronic diseases, some research that has been done on the topic thus far, and how mobile health apps...
Is at-home testing part of the solution to reducing NHS waiting times?
Keeping track of different aspects of one’s health helps to identify patterns that may be influencing one’s disease activity. By identifying patterns,...
Using Mobile Technology to Manage Chronic Diseases
There has been a significant increase in the use of mobile technology for the purposes of managing LTC’s (long-term conditions), such as Inflammatory Bowel...
Mobile Health Apps: A History
There are many reasons as to why mobile health apps have been developed over the years. Aside from the benefits of this mode of care, there was a clear need...
Reducing DNAs in the NHS by Digitising Pathways
The introduction and integration of digital health technologies and solutions, and the resulting digitisation of NHS pathways can significantly reduce the...
The NHS Elective Recovery Fund: How digital tools are helping to clear the NHS backlog
The COVID-19 pandemic has exacerbated the already large backlog facing the NHS, with an estimated six million people still awaiting hospital treatments. In...
The Role of DTx in the Self-Management of Chronic Diseases
by Ampersand Health
Digital therapeutics are particularly well suited to the management of chronic disease, like IBD, rheumatoid arthritis and dermatitis.
Our HealthSuite can help manage a range of inflammatory conditions
Our research and development focuses on the full breadth of inflammatory and immuno-mediated conditions, enabling us to build an exciting roadmap of digital medicines.
Currently, an observational trial is underway that is looking into the effectiveness of using a mobile application to collect Patient Reported Outcome data of those receiving treatment for Neuroendocrine Tumours.
This study is being conducted by King's College Hospital, along with a national charity and a major pharmaceutical company. Individuals who live with Neuroendocrine Tumours live a lower quality of life due to their condition. We are exploring the role digital therapeutics could play to alleviate treatment burden and improve clinical coordination to help patients gain a better quality of life.
Sickle Cell Disease
A leading NHS Trust and The Health Foundation are researching how our My Blood app can improve the process of collecting information from patients to avoid unnecessary trips to the hospital.
The My Blood app helps patients recieve remote care and could alleviate treatment burden, leading to benefits for both clinicians and patients.
Our app content is co-created with leading experts from 2 London hospitals.
NHS - Barts Health & King's College Hospital
We are partnered with the NHS, the world’s largest public health provider.
Our partnership with the NHS has allowed us to perform significant research and gain invaluable insights into the conditions that we focus on.
We have partnered with national charities, such as Crohn’s and Colitis UK.
Our partnerships with national charities allow us to gain important insights into the experiences of the communities we work with.
Our platform has been assessed and approved by NICE, The National Institute for Health and Care Excellence.
Our innovation has been funded by competitive grants from Innovate UK.
Our platform is regulated by the Medicines and Healthcare Products Regulatory Agency.
Our app received the top rating by ORCHA, who are world leaders in health app evaluations.